Angiotensin-converting enzyme genotype may predict survival following major trauma

Emergency Medicine Journal

Volumn 25, Issue 11, 2008, Pages 759-761

  Kehoe, Anthony D ^a   Eleftheriou, K I ^a   Heron, M ^b   Coats, T J ^c   Montgomery, H E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; AGE; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GENDER; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INJURY; INJURY SCALE; LEUKOCYTE; MALE; MORTALITY; PRIORITY JOURNAL; REVISED TRAUMA SCORE; SCORING SYSTEM; UNITED KINGDOM;

ADULT; AGE FACTORS; FEMALE; GENOTYPE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; SURVIVAL ANALYSIS; WOUNDS AND INJURIES;

EID: 56249115930     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2006.045336     Document Type: Article

References (11)

1. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
2. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-50.
3. Harding D, Baines PB, Brulll D, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002; 165:1103-6.
4. Ariza M, Matarin MD, Junque C, et al. Influence of Angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. J Neuropsychiatry Clin Neurosci 2006;18:39-44.
5. Pola E, Gaetani E, Pola R, et al. Angiotensin-converting enzyme gene polymorphism may influence blood loss in a geriatric population undergoing total hip arthroplasty. J Am Geriatr Soc 2002;50:2025-8.
6. Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436:112-6.
7. Baranov D, Armstead WM. Selective blockade of AT1 receptor attenuates impairment of hypotensive autoregulation and improves cerebral blood flow after brain injury in the newborn pig. Anesthesiology 2003;99:1118 24.
8. Guba M, Steinbauer M, Buchner M, et al. Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 2000; 13:190-6.
9. Lobo SM, Lobe FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-9.
10. Reilly PM, Wilkins KB, Fuh KC, et al. The mesenteric hemodynamic response to circulatory shock: an overview. Shock 2001;15:329-43.
11. Laesser M, Spak E, Ewert S, et al. Candesartan improves survival following severe hypovolemia in pigs: a role for the angiotensin II type 2 receptor? Intensive Care Med 2005; 31:1109-15.